Biomarin Pharmaceutical (BMRN) Com Stk USD0.001
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Financial results for the last 5 years
Values are quoted in the stock's local currency: US dollar.
Income Statement: | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 |
---|---|---|---|---|---|
$ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | |
Revenue: | 1,704.05 | 1,491.21 | 1,313.65 | 1,116.85 | 889.90 |
Operating Profit / (Loss): | (100.46) | (123.52) | (14.70) | (803.43) | (110.70) |
Net Interest: | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax: | (94.81) | (142.71) | (35.88) | (831.05) | (154.72) |
Profit after tax from continuing operations: | (23.85) | (77.21) | (117.04) | (630.21) | (171.80) |
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | n/a | n/a | n/a | n/a |
Profit for the period: | n/a | n/a | n/a | n/a | n/a |
Attributable to: | |||||
Equity holders of parent company: | n/a | n/a | n/a | n/a | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Dividend Paid: | c n/a | c n/a | c n/a | c n/a | c n/a |
Retained Profit / (Loss) for the Financial Year: | c n/a | c n/a | c n/a | c n/a | c n/a |
Earnings per Share: | |||||
Basic: | -13.00¢ | -44.00¢ | -67.00¢ | -380.00¢ | -107.00¢ |
Diluted: | n/a | n/a | n/a | n/a | n/a |
Adjusted: | -13.00¢ | -44.00¢ | -67.00¢ | -380.00¢ | -107.00¢ |
Dividend per Share: | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet: | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 |
$ (Millions) | |||||
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | 1,010.87 | n/a | n/a | n/a | n/a |
Intangible Assets: | 653.62 | n/a | n/a | n/a | n/a |
Investment Properties: | n/a | n/a | n/a | n/a | n/a |
Investments: | n/a | n/a | n/a | n/a | n/a |
Other Financial Assets: | 0.00 | n/a | n/a | n/a | n/a |
Other Non-Current Assets: | 1,083.41 | n/a | n/a | n/a | n/a |
2,747.90 | n/a | n/a | n/a | n/a | |
Current Assets: | |||||
Inventories: | 680.27 | n/a | n/a | n/a | n/a |
Trade and Other Receivables: | n/a | n/a | n/a | n/a | n/a |
Cash at Bank & In Hand: | 437.45 | n/a | n/a | n/a | n/a |
Current Asset Investments: | n/a | n/a | n/a | n/a | n/a |
Other Current Assets: | 824.42 | n/a | n/a | n/a | n/a |
1,942.14 | n/a | n/a | n/a | n/a | |
Other Assets: | n/a | n/a | n/a | n/a | n/a |
Total Assets: | 4,690.04 | n/a | n/a | n/a | n/a |
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities: | 932.50 | n/a | n/a | n/a | n/a |
932.50 | n/a | n/a | n/a | n/a | |
Net Current Assets: | c 1,009.64 | c n/a | c n/a | c n/a | c n/a |
Non-Current Liabilities: | |||||
Borrowings: | 486.24 | n/a | n/a | n/a | n/a |
Provisions: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Liabilities: | 148.92 | n/a | n/a | n/a | n/a |
635.16 | n/a | n/a | n/a | n/a | |
Other Liabilities: | n/a | n/a | n/a | n/a | n/a |
Total Liabilities: | 1,567.66 | n/a | n/a | n/a | n/a |
Net Assets: | 3,122.38 | n/a | n/a | n/a | n/a |
Capital & reserves: | |||||
Share Capital: | n/a | n/a | n/a | n/a | n/a |
Share Premium Account: | n/a | n/a | n/a | n/a | n/a |
Other Reserves: | n/a | n/a | n/a | n/a | n/a |
Retained Earnings: | n/a | n/a | n/a | n/a | n/a |
Shareholders Funds: | 3,122.38 | n/a | n/a | n/a | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Equity: | 3,122.38 | n/a | n/a | n/a | n/a |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.